Adverse events ( AEs ) were similar between the two enzalutamide age groups , with the exception of an increase in patients@ years in the rates of all grade peripheral edema ( @ % versus @ % ) , fatigue ( @ % versus @ % ) , and diarrhea ( @ % versus @ % ) .